396 filings
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
8 Jan 24
Departure of Directors or Certain Officers
7:30am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
15 Dec 23
Changes in Registrant's Certifying Accountant
7:30am
8-K
sekeopar tw2di
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
bpyxq1sqt4w
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
EFFECT
taqy9p1vuf ysv
17 Oct 23
Notice of effectiveness
12:15am
424B3
t3ci2
16 Oct 23
Prospectus supplement
4:31pm
UPLOAD
9eba2eaajo8xy v576nk
12 Oct 23
Letter from SEC
12:00am
CORRESP
brx5nwa2f 95onhqff
12 Oct 23
Correspondence with SEC
12:00am
8-K
d2aiq f6fvdmpi6
11 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
D
1teaklcuzu0 inyy7ump
10 Oct 23
$15.12 mm in equity / options / securities to be acquired, sold $7.50 mm, 4 investors
7:40am
8-K
x34fbd
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
S-8
q5k6jp5v8mltpzzup2
25 Aug 23
Registration of securities for employees
5:01pm
DEFA14A
wpo3f17 10l
25 Aug 23
Additional proxy soliciting materials
4:21pm
8-K
xu6i nvon
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am